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Lipid studies in the context of cystic fibrosis have been addressed from two perspectives: the analysis of lipid metabolites in a given
tissue at a particular time point, and the metabolic studies that involve tracing of specific molecules. This review summarizes the methods
used to date.
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content of lipid metabolites in the blood and tissues from
patients and models, sometimes attributed to low fat intake
or malabsorption, sometimes to metabolic alterations or to
increased oxidative status. It is still unclear whether these
changes are or not related to a defect in the CFTR gene, in
part because of the variations in the models studied, in part
due to the particular difficulties that the study of lipid
molecules implies. This responds, on the one hand, to the
variety of methods and the lack of a standardised protocol;
on the other, to the limited stability of lipid molecules,
which show an extreme easiness to degrade and a high
metabolic turnover.
Lipid studies can be addressed from two perspectives: the
analysis of lipid metabolites in a given tissue at a particular
time point, and the metabolic studies that involve tracing of
specific molecules. In both cases most of the studies require
an extraction step by means of organic solvents. Many
extraction methods have been described, depending on the
target molecules. Subsequently, the analysis will be per-1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
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(M. Ollero).formed either on the total organic extract, or on one single
lipid class in particular. In CF studies, lipid classes (phos-
pholipids, cholesterol-esters, non-esterified fatty acids, and
glycerides) have been isolated by thin layer chromatography
(TLC) in silica-gel plates or by solid phase column chroma-
tography in aminopropyl-bonded silica columns. In most
cases alterations in lipid content in CF have been associated
to membrane phospholipids. These have been resolved for
preparative purposes by TLC, which includes scraping of
silica and further extraction, requiring a special care respect
to oxidation. An alternative technology for separation of lipid
classes and individual phospholipids is high-performance
liquid chromatography (HPLC), using normal phases with
UV and evaporative light scattering detection.
Most of the differences found between CF individuals and
controls correspond to the content in individual fatty acids.
Starting in the decade of the 1960s, fatty acid profiles of
serum and plasma, and more recently of CFTR-expressing
tissues are the most abundant studies. For this purpose,
capillary gas–liquid chromatography (GC) has always been
the technology of choice, with its two variants, flame
ionization detection (GC-FID), and mass spectrometry
(GC/MS). Although the ability to resolve peaks is compara-
ble in both, the latter includes verification of peak identity by
its particular mass spectrum, and may potentially rule out the
problems derived from comigration of compounds. In both
cases, a previous derivatization of samples is necessary to
reduce the reactivity and increase the volatility of fatty acyl
chains. In most laboratories fatty acid methyl ester (FAME)ed by Elsevier B.V. All rights reserved.
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and/or methanol-BF3, but alternatively extraction and trans-
esterification can be performed in one step (direct trans-
methylation) by methanol-benzene or methanol-hexane and
acetyl-chloride, with positive results. In addition, the posi-
tion or stereospecificity of fatty acyl chains in the glycerol
backbone of phospholipids can be analyzed by sequential
incubation with specific phospholipases, solid phase separa-
tion of phospholipase-released fatty acids, and FAME anal-
ysis by GC [1].
The excessive inflammation and altered oxidation pattern
characteristic of CF, have made other hydrophobic metab-
olites like eicosanoid derivatives of fatty acids, antioxidants,
and hydroperoxides, normal subjects of analysis, especially
in the last two decades. Leukotrienes have been analyzed by
enzymoimmunoassay (EIA), but also by pre-isolation in
solid phase C18 columns followed by reverse-phase HPLC
and radioimmunoassay (RIA). Thromboxanes and prosta-
glandins have been quantified by RIA and EIA, and also by
stable isotope dilution and GC-MS [2]. Reverse-phase
HPLC has been successful for resolution and quantitation
of antioxidants like h-carotene, a-tocopherol, and retinol, as
well as to evaluate the production of lipid hydroperoxides,
although the latter has usually been addressed fluorometri-
cally by the standard thiobarbituric acid method, or indi-
rectly by the study of peroxide-induced hemolysis.
Metabolic studies comprise a more dynamic strategy to
address lipid alterations in CF. One approach is the analysis
in vitro of radioactive metabolites upon incubation of cells
with labeled fatty acids. This allows the study of fatty acid
release and incorporation and, for instance, the study of
eicosanoid production from arachidonic acid, by furtherTLC analysis [3], or the evaluation of lipolytic activity in
plasma from 14C-oleoyl glycerol as substrate. The use of
stable isotopes (13C) facilitates the study in vivo of lipid
digestion, like in the mixed triglyceride breath test (MTG),
or in the analysis of 13C-palmitic acid in stools by GC-
isotope ratio mass spectrometry.
Even though almost all of the potential methods have
been already used, some technologies for lipid analysis still
remain to be sufficiently explored in the context of CF. This
is the case of tandem mass spectrometry and the non-
invasive 13C topical nuclear magnetic resonance spectros-
copy, the latter successfully tested for the quantitation of
mono and polyunsaturated fatty acids in adipose tissue of CF
patients. Given the current panoply of techniques and their
variations, the use of a more simplified and comprehensive
methodology would contribute to the integration of lipid
metabolite studies in the postgenomic era, and to solve some
of the unanswered questions in CF.References
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